About Index Trending news
Analyze
Top 50 Pricing
Polyneuron

Polyneuron

Work at Polyneuron? Add yourself to this profile

Polyneuron

Swiss biotech start-up. We’re using our Antibody-Catch® technology to develop the most accurate treatment of rare autoimmune disorders.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Seed fund
Zürcher Kantonalbank, EVA Basel
Employees

Unknown size

Locations
HQ
Headquarters
Seed fund
startupticker

Polyneuron Pharmaceuticals closes CHF 3 Million seed financing round.ch | The Swiss Startup News channel

Health Funding